Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
CROI 2017
feb 2017
jun 2024 | Niertransplantatie, Stamceltransplantatie, Virale infecties